remained News newsbot.ch

Wirtschaft »

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

2019-09-02 22:40:14


Wirtschaft »

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

2019-06-04 19:20:00



Suchresultate als RSS-Feed